ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 183 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 4.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $246 | -87.4% | 22 | -75.8% | 0.00% | – |
| Q2 2023 | $1,947 | +337.5% | 91 | +727.3% | 0.00% | – |
| Q1 2023 | $445 | -75.5% | 11 | -71.8% | 0.00% | – |
| Q4 2022 | $1,814 | +81.4% | 39 | +200.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 13 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -83.3% | 13 | -84.9% | 0.00% | -100.0% |
| Q1 2022 | $6,000 | +500.0% | 86 | +561.5% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 13 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 13 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 13 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 13 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 13 | -45.8% | 0.00% | – |
| Q3 2020 | $1,000 | -66.7% | 24 | -54.7% | 0.00% | -100.0% |
| Q2 2020 | $3,000 | +50.0% | 53 | +60.6% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |